Publications by authors named "Finbar O'Callaghan"

Claim this Profile
A
Availability and affordability of cannabinoids for epilepsy treatment across different geographic settings-A survey from the ILAE Plant-Based Therapy Task Force.
Kollencheri Puthenveettil Vinayan, Ali Akbar Asadi-Pooya, Aruna Setumadhava Jyotsna, Nithya N Kumar, Siegward-M Elsas, Finbar O'Callaghan

Epilepsia· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blueprint for clinical N-of-1 strategies with off-label precision treatments in monogenic epilepsies.
Victoria M Defelippe, Eva H Brilstra, Willem M Otte, Ghislaine J M W van Thiel, Helen J Cross, Finbar O'Callaghan

Orphanet J Rare Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-of-1 trials in epilepsy: A systematic review and lessons paving the way forward.
Victoria M Defelippe, Eva H Brilstra, Willem M Otte, Helen J Cross, Finbar O'Callaghan

Epilepsia· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing epilepsy diagnostic and treatment gaps: Standardized paediatric epilepsy training courses for health care professionals.
Alison Gifford, Michael J Griffiths, Philippa Rodie, Jo Wilmshurst, Jessica Ball, Finbar O'Callaghan

Dev Med Child Neurol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to updated clinical recommendations for the management of tuberous sclerosis complex associated epilepsy.
Sam Amin, Finbar O'Callaghan

Eur J Paediatr Neurol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Classic ketogenic diet versus further antiseizure medicine in infants with drug-resistant epilepsy (KIWE): a UK, multicentre, open-label, randomised clinical trial.
Natasha E Schoeler, Louise Marston, Laura Lyons, Sally Halsall, Ruchika Jain, Finbar O'Callaghan

Lancet Neurol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward responsible clinical n-of-1 strategies for rare diseases.
Victoria M Defelippe, Ghislaine J M W van Thiel, Willem M Otte, Roger E G Schutgens, Bas Stunnenberg, Finbar O'Callaghan

Drug Discov Today· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epilepsy and cannabis: so near, yet so far.
Martin Kirkpatrick, Finbar O'callaghan

Dev Med Child Neurol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of infantile spasms in tuberous sclerosis complex.
Finbar J O'Callaghan

Eur J Paediatr Neurol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Historical Patterns of Diagnosis, Treatments, and Outcome of Epilepsy Associated With Tuberous Sclerosis Complex: Results From TOSCA Registry.
Rima Nabbout, Elena Belousova, Mirjana P Benedik, Tom Carter, Vincent Cottin, Finbar O'Callaghan

Front Neurol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA).
Matthias Sauter, Elena Belousova, Mirjana P Benedik, Tom Carter, Vincent Cottin, Finbar O'Callaghan

Orphanet J Rare Dis· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Add-on Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex: A Placebo-Controlled Randomized Clinical Trial.
Elizabeth A Thiele, E Martina Bebin, Hari Bhathal, Floor E Jansen, Katarzyna Kotulska, Finbar J O'Callaghan

JAMA Neurol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TuberOus SClerosis registry to increAse disease awareness (TOSCA) Post-Authorisation Safety Study of Everolimus in Patients With Tuberous Sclerosis Complex.
J Chris Kingswood, Elena Belousova, Mirjana P Benedik, Klemens Budde, Tom Carter, Finbar O'Callaghan

Front Neurol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The metformin in tuberous sclerosis (MiTS) study: A randomised double-blind placebo-controlled trial.
Sam Amin, Andrew A Mallick, Hannah Edwards, Mario Cortina-Borja, Matthew Laugharne, Finbar J K O'Callaghan

EClinicalMedicine· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Foreword.
Finbar O'Callaghan

Dev Med Child Neurol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic algorithm for children presenting with epilepsia partialis continua.
Snehal Surana, Thomas Rossor, Jane Hassell, Stewart Boyd, Felice D'Arco, Finbar O'Callaghan

Epilepsia· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylactic Antiepileptic Treatment in Tuberous Sclerosis.
Prerna Choudhury, Robert Spaull, Sam Amin, Andrew A Mallick, Jayesh S Patel, Finbar O'Callaghan

Pediatr Neurol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural clusters of tuberous sclerosis complex (TSC)-associated neuropsychiatric disorders (TAND): new findings from the TOSCA TAND research project.
Petrus J de Vries, Elena Belousova, Mirjana P Benedik, Tom Carter, Vincent Cottin, Finbar O'Callaghan

J Neurodev Disord· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal Manifestations of Tuberous Sclerosis Complex: Key Findings From the Final Analysis of the TOSCA Study Focussing Mainly on Renal Angiomyolipomas.
J Chris Kingswood, Elena Belousova, Mirjana P Benedik, Tom Carter, Vincent Cottin, Finbar O'Callaghan

Front Neurol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of Illness and Quality of Life in Tuberous Sclerosis Complex: Findings From the TOSCA Study.
Anna C Jansen, Stephanie Vanclooster, Petrus J de Vries, Carla Fladrowski, Guillaume Beaure d'Augères, Finbar O'Callaghan

Front Neurol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tuberous Sclerosis Complex-Associated Neuropsychiatric Disorders (TAND): New Findings on Age, Sex, and Genotype in Relation to Intellectual Phenotype.
Petrus J de Vries, Elena Belousova, Mirjana P Benedik, Tom Carter, Vincent Cottin, Finbar O'Callaghan

Front Neurol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations between macrolide antibiotics prescribing during pregnancy and adverse child outcomes in the UK: population based cohort study.
Heng Fan, Ruth Gilbert, Finbar O'Callaghan, Leah Li

BMJ· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tuberous Sclerosis Complex (TSC): Expert Recommendations for Provision of Coordinated Care.
Nicholas M P Annear, Richard E Appleton, Zahabiyah Bassi, Rupesh Bhatt, Patrick F Bolton, Finbar J O'Callaghan

Front Neurol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The TOSCA Registry for Tuberous Sclerosis-Lessons Learnt for Future Registry Development in Rare and Complex Diseases.
Ruben Marques, Elena Belousova, Mirjana P Benedik, Tom Carter, Vincent Cottin, Finbar O'Callaghan

Front Neurol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis